NMNAT1 Antikörper (N-Term)
Kurzübersicht für NMNAT1 Antikörper (N-Term) (ABIN629615)
Target
Alle NMNAT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- NMNAT1 antibody was raised against the N terminal of NMNAT1
-
Aufreinigung
- Purified
-
Immunogen
- NMNAT1 antibody was raised using the N terminal of NMNAT1 corresponding to a region with amino acids PVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVL
-
-
-
-
Applikationshinweise
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
NMNAT1 Blocking Peptide, (ABIN5615010), is also available for use as a blocking control in assays to test for specificity of this NMNAT1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NMNAT1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NMNAT1 (Nicotinamide Nucleotide Adenylyltransferase 1 (NMNAT1))
-
Andere Bezeichnung
- NMNAT1
-
Hintergrund
- The coenzyme NAD and its derivatives are involved in hundreds of metabolic redox reactions and are utilized in protein ADP-ribosylation, histone deacetylation, and in some Ca(2+) signaling pathways. NMNAT (EC 2.7.7.1) is a central enzyme in NAD biosynthesis, catalyzing the condensation of nicotinamide mononucleotide (NMN) or nicotinic acid mononucleotide (NaMN) with the AMP moiety of ATP to form NAD or NaAD.
-
Molekulargewicht
- 32 kDa (MW of target protein)
Target
-